Robin L. Fisher

556 total citations
8 papers, 440 citations indexed

About

Robin L. Fisher is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Robin L. Fisher has authored 8 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Virology and 4 papers in Emergency Medicine. Recurrent topics in Robin L. Fisher's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV-related health complications and treatments (4 papers). Robin L. Fisher is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV-related health complications and treatments (4 papers). Robin L. Fisher collaborates with scholars based in United States, Netherlands and Australia. Robin L. Fisher's co-authors include Jaime E. Hernández, Grace A. McComsey, Vanessa C. Williams, J Tyler Lonergan, Peter Shalit, Douglas Ward, Lisa Ross, Michael Sension, Mark S. Shaefer and Joseph J. Eron and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Robin L. Fisher

8 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin L. Fisher United States	7	332	269	254	59	25	8	440
Girish Prajapati United States	10	249 0.8×	172 0.6×	95 0.4×	179 3.0×	13 0.5×	25	436
Elisabeth H. Gisolf Netherlands	10	328 1.0×	153 0.6×	235 0.9×	112 1.9×	6 0.2×	17	425
Martine Lévine France	6	302 0.9×	256 1.0×	205 0.8×	67 1.1×	20 0.8×	7	415
Sara Melzi Italy	9	270 0.8×	153 0.6×	154 0.6×	59 1.0×	7 0.3×	10	377
Sandy Griffith United States	10	442 1.3×	78 0.3×	322 1.3×	115 1.9×	27 1.1×	17	507
Marukh Bamji United States	9	310 0.9×	211 0.8×	207 0.8×	115 1.9×	9 0.4×	12	481
Nkuli Mashabane South Africa	5	356 1.1×	302 1.1×	200 0.8×	74 1.3×	18 0.7×	7	478
Lisa Hamzah United Kingdom	13	430 1.3×	289 1.1×	139 0.5×	142 2.4×	20 0.8×	42	531
Laura Carenzi Italy	10	173 0.5×	159 0.6×	103 0.4×	53 0.9×	11 0.4×	18	279
Esther Francia Spain	9	251 0.8×	299 1.1×	248 1.0×	94 1.6×	45 1.8×	13	500

Countries citing papers authored by Robin L. Fisher

Since Specialization

Citations

This map shows the geographic impact of Robin L. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin L. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin L. Fisher more than expected).

Fields of papers citing papers by Robin L. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin L. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin L. Fisher. The network helps show where Robin L. Fisher may publish in the future.

Co-authorship network of co-authors of Robin L. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Robin L. Fisher. A scholar is included among the top collaborators of Robin L. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin L. Fisher. Robin L. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Lonergan, J Tyler, Grace A. McComsey, Robin L. Fisher, et al.. (2004). Lack of Recurrence of Hyperlactatemia in HIV-Infected Patients Switched From Stavudine to Abacavir or Zidovudine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(4). 935–942. 15 indexed citations

McComsey, Grace A., J Tyler Lonergan, Charles L. Hoppel, et al.. (2004). Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS. 19(1). 15–23. 136 indexed citations

McComsey, Grace A., Douglas Ward, Michael Sension, et al.. (2004). Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study. Clinical Infectious Diseases. 38(2). 263–270. 148 indexed citations

Scarsella, Anthony, Gregg Coodley, Peter Shalit, et al.. (2002). Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: Effect of stavudine exposure and antiretroviral experience. Advances in Therapy. 19(1). 1–8. 19 indexed citations

Henry, Keith, Robert Wallace, Robin L. Fisher, et al.. (2001). Twice‐Daily Triple Nucleoside Intensification Treatment with Lamivudine‐Zidovudine plus Abacavir Sustains Suppression of Human Immunodeficiency Virus Type 1: Results of the TARGET Study. The Journal of Infectious Diseases. 183(4). 571–578. 20 indexed citations

DeMasi, Ralph, Neil M.H. Graham, Jerry M. Tolson, et al.. (2001). Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Advances in Therapy. 18(4). 163–173. 50 indexed citations

Eron, Joseph J., Peter Ruane, Stephen Becker, et al.. (2000). Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS. 14(6). 671–681. 49 indexed citations

Li, Ping, et al.. (1996). INCREASED RESISTANCE TO ACETAMINOPHEN-INDUCED HEPATOTOXICITY IN RETROVIRUS-INFECTED MICE. Biopharmaceutics & Drug Disposition. 17(8). 661–674. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact